UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐ No ☒ FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended August 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______, 20 ____, to ______, 20_____. Commission F ...

| --- | --- | --- | --- | --- | --- | --- | --- | |-------|-------|-------|--------------------------------------|----------------|-------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | NOVO INTEGRATED | SCIENCES, INC. | | | | | | | | NASDAQ: NVOS Investor Presentation | | | | | | | | | October 2021 | | | | | DISCLAIMER Disclaimers and Cautionary Statements: The information contained in this presentation is provided by Novo Integrated Scien ...